Early identification program for first-episode psychosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of the PRESTO program, which facilitates early identification and access to specialized care for patients experiencing first-episode psychosis (FPE). By focusing on reducing the duration of untreated psychosis (DUP), the study seeks to improve the prognosis for individuals diagnosed with schizophrenia and related disorders. The intervention addresses barriers such as stigma and lack of awareness in the primary care network, which contribute to prolonged DUP. The study will also analyze factors influencing the implementation of this intervention for potential broader application.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or brief psychotic disorder established according to DMS 5
* Never having taken neuroleptic treatment for antipsychotic purposes, except for the current episode and for a duration of \< 6 month
* Oral consent of the patient or, for minors, of his/her parents to participate in the study

Exclusion Criteria:

* Patients already treated and followed for FPE
* Brief psychotic state not requiring specific management

Where it's running

• Hospices Civils de Lyon
  Bron, France Recruiting
• Chu Clermont-Ferrand
  Clermont-Ferrand, France Recruiting
• Chu Grenoble
  Grenoble, France Recruiting
• CHU de Montpellier
  Montpellier, France Recruiting
• CHU de Nîmes
  Nîmes, France Recruiting
• Chu Saint Etienne
  Saint-Etienne, France Recruiting

Study contacts

• Principal investigator: Eric FAKRA, MD PhD — Centre Hospitalier Universitaire de Saint Etienne
• Study coordinator: Eric FAKRA, MD PhD
• Email: eric.fakra@chu-st-etienne.fr
• Phone: (0)477127885

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Add CBD to antipsychotic treatment for first-episode psychosis to see if it helps more than placebo

  This study tests whether adding cannabidiol (CBD) to ongoing antipsychotic treatment helps people with a first episode of psychosis who haven’t fully responded to their first antipsychotic, compared with a placebo.

  Recruiting at 2 sites Phase 3 University of Oxford · Vienna and 16 other locations · NCT06778564

• Using computer-assisted music to help young patients with their first psychotic episode

  This study is testing if using computer-assisted music can help young adults with their first psychotic episode improve their memory and thinking skills.

  Recruiting University Hospital, Caen · Caen · NCT05880719

• Impact of case manager intervention on psychotic episode recurrence in young adults

  This study tests whether having a trained case manager can help young adults aged 16 to 30 who have had their first psychotic episode avoid having more episodes.

  Recruiting at 3 sites Centre Hospitalier Universitaire de Nīmes · Toulouse, Choisir Une Région and 5 other locations · NCT05116514

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.